FEBRUARY 19, 2012
Notice
  • Sorry! That page cannot be found.

Cost-Consequence Analysis Evaluating the Use of Botulinum Neurotoxin-A in Patients with Detrusor Overactivity Based on Clinical Outcomes Observed at a Single UK Centre

E-mail Print

Objective: This study aimed to assess the resource utilisation, health benefits and cost-effectiveness of intra-detrusor injections of botulinum neurotoxin-A (BoNT/A) in patients with overactive bladder (OAB).




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |